Skip to content

Allotment

Bio Medica Laboratories

Bio Medica Laboratories IPO will open on May 21, 2026 and will close on May 25, 2026. This IPO is a book-built issue, where the company aims to raise around ₹[.] crores. The issue includes a fresh issue of ₹[.] crores along with an offer for sale of up to 3,76,800 equity shares having a face value of ₹10 each.

The price band for Bio Medica Laboratories IPO has been fixed at ₹[.] to ₹[.] per share. The quota allocation consists of 35% for retail investors, 50% for QIBs, and 15% for HNIs. The IPO is scheduled to be listed on NSE on May 28, 2026, while the allotment date is expected on May 26, 2026.

In terms of financial performance, the company reported revenue of ₹38.33 crores in 2025 against ₹15.34 crores in 2024. The company reported profit of ₹9.79 crores in 2025 compared to profit of ₹2.50 crores in 2024. As per the financials, investors may consider applying to the IPO for a long-term perspective.

Bio Medica Laboratories IPO & Charts
₹112

0%

Open

₹112

HIgh - Low

₹112

Previous Close

₹112

Total Traded Value

0

52 Weeks High

₹112

52 Weeks Low

₹112

Updates On

Feb 25, 2026

IPO. Open

May 21, 2026

IPO. Close

May 25, 2026

IPO. Price

₹00.00

IPO Market price

₹174.79 Cr

IPO Details

IPO Date 28 May
IPO Listing Date 28 May
IPO Face Value ₹10 Per Equity Share
IPO Price Range ₹00.00
IPO Issue Size 37,71,600 Equity Shares
IPO Sale Type Fresh Capital
Employee Discount -
IPO Issue Type Book build Issue
IPO Listing NSE SME Platform
Share Holding Pre Issue 91,80,001 shares

IPO Timeline

IPO Open Date 21 May
IPO Close Date 25 May
IPO Allotment (Tentative) 26 May
Refunds 27 May
Credit to Demat Account 27 May
IPO Listing Date 28 May

IPO Lot Size

About Company

BIO MEDICA LABORATORIES LIMITED is a leading parenteral manufacturing company based in Central India, known for its strong focus on quality, innovation, and healthcare excellence. The company specializes in producing a wide range of parenteral formulations, including injectables for human and veterinary applications. Built on a foundation of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), BIO MEDICA ensures that every product meets strict international standards of safety, purity, and effectiveness. Its modern manufacturing facilities are equipped with advanced technology, enabling consistent production of high-quality injectable solutions for domestic as well as global markets.

The company offers a diverse portfolio of injectable products designed to meet the needs of hospitals, healthcare providers, and veterinary care sectors. With a growing export presence, BIO MEDICA LABORATORIES LIMITED continues to expand its global footprint by delivering reliable healthcare solutions worldwide. The organization is driven by a strong mission to improve health and well-being through innovative parenteral formulations for both humans and animals. Its vision is to become a globally recognized leader in the pharmaceutical manufacturing industry by maintaining excellence, sustainability, and continuous improvement in all aspects of its operations.

-

Company Financials (Consolidated)

Assets 31.81 24.77 18.35
Total Income 105.35 102.06 66.37
Profit After Tax 9.04 8.22 4.64
EBITDA 12.4 10.86 6.04
Net Worth 23.37 14.34 6.12
Reserves and Surplus 10.75 14.29 6.07
Total Borrowing 3.62 5.05 4

Key Performance Indicator (KPI)

ROE 99.59%
ROCE 48.20%
Debt/Equity 1.02
RoNW 99.59%
PAT Margin 25.64%
EBITDA Margin 39.83%
Price to book value -
IPO Objective

IPO Objects of the Issue

S.No. Objects of the ipo Resources Detail IPO Amount
1 Funding capital expenditure requirements for the purchase of equipment/machineries -
2 To meet out the expenses of Working Capital Requirement -
3 To meet out the General Corporate Purposes; -
4 Offer for Sale (OFS) -

Contact Details

Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: companysecretary@biomedica.co.in
Website: http://www.biomedica.co.in/

Detail Registrar

Skyline Financial Services Pvt.Ltd.
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php

FAQ

Compare:

Back To Top